FSD Pharma Inc. functions as a biotechnology firm dedicated to the discovery... FSD Pharma Inc. functions as a biotechnology firm dedicated to the discovery and advancement of pharmaceutical products. Its main drug candidate, FSD201, is a palmitoylethanolamide currently undergoing development for addressing inflammatory conditions. Furthermore, the company is pursuing research and development into Lucid-Psych, a molecular compound targeting mental health challenges, and Lucid-MS, another molecular compound designed for neurodegenerative illnesses. FSD Pharma Inc. maintains its corporate headquarters in Toronto, Canada.
